Data catalogue

The aim of this catalogue is to make it easier to find data published by the EMCDDA. Currently, the list only contains a fraction of all data published by the agency over the years but we are adding to it all the time as part of our commitment to open data. Note that the aim of this catalogue is not necessarily to provide the data itself (though it may do so in some cases) but mainly to allow you to find the data.

The catalogue incudes:

  • The Statistical Bulletin which is mainly based on data submitted to the agency by the Reitox network of national focal points for the main reporting countries (27 EU Member States plus Türkiye and Norway) on a yearly basis and which forms the basis for the EMCDDA's annual overview of the drug situation in Europe, as well as other key outputs. These data are generally at the national level. The topics covered by these data sets include general population surveys, drug-related deaths, drug-related infectious diseases, treatment demand, markets and seizures data, etc. Only the most recent Statistical Bulletins are currently included.
  • Data from ongoing collaborations with networks or partner organisations, These data sets are usually at the city-level and are considered complementary sources to the main reported data sets. Examples include data from SCORE (wastewater), TEDI (drug.checking), Euro-DEN (hospital emergencies), ESCAPE (syringe residues), etc.
  • Data from studies or specific projects. These data sets are usually once-off and may be the result of primary research or based on aggregation of other existing data sets, or some combination of both. These data in the past have not been published in 'raw format' but are often included in PDFs or only made available as graphics, etc. Data from non-reporting countries (e.g. countries in the EU neighbourhood) are often published in this format,
  • Data which has been manipulated, combined, or further processed for the purposes of analysis, data visualisation or similar. This is almost always done when included as part of a publication or output and usually referred to as the 'source data'.
  • Data about the EMCDDA or activities e.g. accounts, expenditure or other data about the agency.
Title Publication date Data series Keywords
Annual accounts 2020 EMCDDA
Statistical Bulletin 2021 — drug law offences DLO criminal justice system, drug law offences, drug markets, law
Statistical Bulletin 2021 — drug use and prison DUP amphetamine, cannabis, cocaine, heroin, MDMA/ecstasy, methamphetamine, prison
Statistical Bulletin 2021 — health and social responses HSR health and social responses, OAT (opioid agonist treatment), treatment provision
Statistical Bulletin 2021 – prevalence and patterns of drug use in the general population alcohol, amphetamine, cannabis, cocaine, general population surveys (GPS), key indicators, LSD, MDMA/ecstasy, prevalence and patterns of drug use, tobacco, Gender and drugs, young people
Statistical Bulletin 2021 — price, purity and potency PPP amphetamine, cannabis, cocaine, drug markets, heroin, LSD, MDMA/ecstasy, methamphetamine, potency/purity, price, supply of drugs, supply reduction
Statistical Bulletin 2021 — problem drug use PDU injecting drug use, key indicators, problem drug use, Gender and drugs
Statistical Bulletin 2021 — seizures of drugs SZR amphetamine, cannabis, cocaine, drug markets, LSD, MDMA/ecstasy, methamphetamine, seizures of drugs, supply of drugs, supply reduction, trafficking
Statistical Bulletin 2021 — treatment demand data TDI cannabis, cocaine, heroin, key indicators, methamphetamine, TDI (key indicator), treatment of drug use, Gender and drugs
Statistical Bulletin 2021— overdose deaths DRD DRD (key indicator), drug-related deaths, health harms of drug use, key indicators, overdose, Gender and drugs
Data table: analysis of national drug policy evaluations reported to the EMCDDA policy, policy evaluation
Drug law offences (Statistical Bulletin 2020) DLO criminal justice system, drug law offences, drug markets, law
Statistical Bulletin 2020 — drug use in prison DUP amphetamine, cannabis, cocaine, heroin, MDMA/ecstasy, methamphetamine, prison
Statistical Bulletin 2020 — drug-related infectious diseases DRID DRID (key indicator), drug-related infectious diseases, hepatitis C virus (HCV), HIV, key indicators
Statistical Bulletin 2020 — health and social responses HSR health and social responses, OAT (opioid agonist treatment), treatment provision
Statistical Bulletin 2020 – prevalence and patterns of drug use in the general population alcohol, amphetamine, cannabis, cocaine, general population surveys (GPS), key indicators, LSD, MDMA/ecstasy, prevalence and patterns of drug use, tobacco, Gender and drugs, young people
Statistical Bulletin 2020 — price, purity and potency PPP amphetamine, cannabis, cocaine, drug markets, heroin, LSD, MDMA/ecstasy, methamphetamine, potency/purity, price, supply of drugs, supply reduction
Statistical Bulletin 2020 — problem drug use PDU injecting drug use, key indicators, problem drug use, Gender and drugs
Statistical Bulletin 2020 — seizures of drugs SZR amphetamine, cannabis, cocaine, drug markets, LSD, MDMA/ecstasy, methamphetamine, seizures of drugs, supply of drugs, supply reduction, trafficking
Statistical Bulletin 2020 — treatment demand data TDI cannabis, cocaine, heroin, key indicators, methamphetamine, TDI (key indicator), treatment of drug use, Gender and drugs
Statistical Bulletin 2020— overdose deaths DRD DRD (key indicator), drug-related deaths, health harms of drug use, key indicators, overdose, Gender and drugs
Statistical Bulletin 2021 — drug-related infectious diseases DRID DRID (key indicator), drug-related infectious diseases, hepatitis C virus (HCV), HIV, key indicators
Statistical Bulletin 2019 — drug-related infectious diseases DRID DRID (key indicator), drug-related infectious diseases, hepatitis C virus (HCV), HIV, key indicators
Statistical Bulletin 2019 – prevalence and patterns of drug use in the general population alcohol, amphetamine, cannabis, cocaine, general population surveys (GPS), key indicators, LSD, MDMA/ecstasy, prevalence and patterns of drug use, tobacco, Gender and drugs, young people
Statistical Bulletin 2019 — price, purity and potency PPP amphetamine, cannabis, cocaine, drug markets, heroin, LSD, MDMA/ecstasy, methamphetamine, potency/purity, price, supply of drugs, supply reduction
Top